MMP14 and neoplasm: In vivo studies have revealed that MMP14 in the TME creates a suitable primary and pre-metastatic niche in the LN for tumour survival during epithelial–mesenchymal transition (EMT) [32–36], which may be attributable for the similar expression profiles of MMP14 at TSI and ENE sites.